What is a key difference between harm reduction and abstinence-based approaches to substance use?

What is a key difference between harm reduction and abstinence-based approaches to substance use?

• A. Abstinence-based approaches require complete cessation of use.
• B. Harm reduction accepts ongoing use with strategies to minimize harm.
• C. Harm reduction rejects any safety strategies.
• D. Abstinence-based approaches promote safer injection practices.

Answer: (B)

The main idea is that harm reduction accepts that people may continue to use substances and focuses on reducing negative consequences through practical strategies. This includes things like naloxone access for overdose reversal, sterile equipment and safe disposal, education on safer use, testing for contaminants, and linking people to treatment and support. Abstinence-based approaches, by contrast, aim for complete cessation of use and provide supports that align with that goal. So why is this the best answer? It captures the essential difference: harm reduction is about minimizing harm even if use continues, whereas abstinence-based programs center on stopping use entirely. The other statements either misstate harm reduction (rejected safety strategies) or mischaracterize abstinence-based goals (promoting safer injection practices).

The main idea is that harm reduction accepts that people may continue to use substances and focuses on reducing negative consequences through practical strategies. This includes things like naloxone access for overdose reversal, sterile equipment and safe disposal, education on safer use, testing for contaminants, and linking people to treatment and support. Abstinence-based approaches, by contrast, aim for complete cessation of use and provide supports that align with that goal.

So why is this the best answer? It captures the essential difference: harm reduction is about minimizing harm even if use continues, whereas abstinence-based programs center on stopping use entirely. The other statements either misstate harm reduction (rejected safety strategies) or mischaracterize abstinence-based goals (promoting safer injection practices).